Global Fibromyalgia Therapeutics Market to Grow 4.3% to 2018 Says New Report

Nov. 1, 2011 - PRLog -- The report “Fibromyalgia Therapeutics: Pipeline Assessment and Market Forecasts to 2018” available at http://www.pharmaceutical-market-research.com/publications/healthcare_market/fibromyalgia_therapeutics.html is an essential source of information and analysis on the global fibromyalgia market. It identifies the key trends shaping and driving the fibromyalgia market and provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.
   
According to the 83 page report, the global market for Fibromyalgia was valued at $1.7 billion in 2010 and is expected to grow at a CAGR of 4.3% hitting $2.4 billion by 2018. The restricted growth in the market is due to the unavailability of approved drugs in the EU and Japan market, expected patent expiry of Cymbalta (2013) and Lyrica (2018) and lack of newer therapies in late stage fibromyalgia therapeutics pipeline.

Recently the FDA (Food and Drug Administration) has approved three drugs for the treatment of FM. Lyrica (pregabalin) was the first drug approved in June 2007 followed by Cymbalta (duloxetine) in June 2008 and Savella (milnacipran) in January 2009. Marketing authorisation of these drugs has been rejected by EMEA (European Medical Agency) due low effectiveness and high adverse reactions associated with the drugs. Cymbalta was the first drug to be rejected by EMEA in 2008, followed by Lyrica in 2009 and Savella in 2010. However, increasing prevalence and diagnosis is expected to drive the future fibromyalgia therapeutics market.

The report “Fibromyalgia Therapeutics: Pipeline Assessment and Market Forecasts to 2018” is available from Piribo at:
http://www.pharmaceutical-market-research.com/publication...

Piribo product ID: GDA03671

About Piribo

Piribo http://www.pharmaceutical-market-research.com/publications/healthcare_market/fibromyalgia_therapeutics.html is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.